title: Cabozantinib in renal cell carcinoma: only a METEOR or a rising star?
abstract: N/A (Letter to the Editor).
authors.affiliation: University Hospital of Parma. bersamel@libero.it.
authors.forename: Melissa
authors.initials: M
authors.lastname: Bersanelli
authors.forename: Sebastiano
authors.initials: S
authors.lastname: Buti
mesh_terms: D000813:Anilides / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D017326:Clinical Trials, Phase III as Topic; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*
chemical_list: D000813:Anilides; D047428:Protein Kinase Inhibitors; D011725:Pyridines; C558660:cabozantinib
keywords: Cabozantinib; METEOR; Renal cell carcinoma; TKI